Table 1.
Change in bone mineral density in women with breast cancer undergoing treatment and receiving calcium and vitamin D supplementation alone or with placebo
Authors | N | Treatments | Time Frame | BMD Change from baseline |
---|---|---|---|---|
Premenopausal women
| ||||
Kim et al.[56] | 112 | 500 mg calcium, 1000 IU vit D | 12 months | Lumbar spine: -7.5%; Femoral Neck: - 3.4% |
Shapiro et al.[57] | 439 | 1000 mg calcium, 400 IU vit D | 12 months | Lumbar spine: ovarian failure:-6.7% |
Hershman et al.[59] | 85 | 1000 mg calcium, 400 IU vit D + placebo | 12 months | Lumbar spine: -5.4%, femoral neck: - 1.5%, total hip: -1.9% |
57 | 1000 mg calcium, 400 IU vit D + placebo | 24 months | Lumbar spine: -6.3%, femoral neck: - 2.4%, total hip: -2.6% | |
Hines et al.[60] | 216 | 600 mg calcium, 400 IU vit D + placebo | 12 months | Lumbar spine: -5.4%, femoral neck: - 2.4%, total hip: -3.4% |
Hershman et al.[58] | 103 | 1000 mg calcium, 400-800 IU vit D + placebo | 12 months | Lumbar spine: -4.39%, femoral neck: - 1.5%, total hip: -2.08% |
Fuleihan et al.[61] | 40 | 500 mg calcium, 400 IU vit D + placebo | 12 months | Lumbar spine: -3.2%, total hip: -2.8%; amenorrhic women lost 4% BMD at both lumbar spine & total hip |
| ||||
Postmenopausal women
| ||||
Prieto-Alhambra et al.[62] | 232 | 1000 mg calcium carbonate, 800 IU vit D + 16,000 IU D3 | 12 months | Total hip: -0.72%, femoral neck: - 1.49%, lumbar spine: -1.68% |
Sergi et al.[63] | 51 | 1000 mg calcium carbonate, 800 IU vit D | 24 months | Lumbar spine: -3%, trochanter: - 4.0%, femoral neck: -4.1%. |
Safra et al.[64] | 90 | 1200 mg calcium carbonate, 400 IU vit D | 12 months | Lumbar spine: -5.89%, |
24 months | Lumbar spine: -6.51%, | |||
Rastelli et al.[65] | 60 | 1000 mg calcium carbonate, 400 IU vit D + 50,000 IU vit D2 | 6 months | Spine: -0.36%, femoral neck: -1.39%, total femur: +0.04% |
Vit D group: Spine: 0.12%, femoral neck: 0.45%, total femur: -0.005% | ||||
Markopoulus et al.[66] | 213 | 1000 mg calcium, 400 IU vit D | 12 months | T ≥ -1: Lateral spine -5.3%; Hip -2.4% |
-2<T<-1: Lateral spine 0%; hip%: - 1.3% | ||||
24 months | T ≥ -1: Lateral spine -2.5%; Hip -5.7% | |||
-2<T<-1: Lateral spine -1.5%; hip: - 3.9% | ||||
Van Poznak et al.[67] | 234 | 1000 mg elemental calcium, 400 IU vit D | 12 months | A only: Lateral spine -0.6%; Hip: - 0.4% |
A+P: Lateral spine -1.2%; Hip: -0.4% | ||||
24 months | A only: Lateral spine -2.1%; Hip: - 0.4% | |||
A+P: Lateral spine -1.8%; Hip: -1.1% | ||||
Ellis et al.[68] | 252 | 1000 mg calcium, ≥ 400 IU vit D + placebo | 24 months | Lumbar spine: -1.5% |
Greenspan et al.[69] | 87 | 500 mg calcium carbonate, 200 IU vit D for participants consuming < 1200 mg dietary calcium | 24 months | Posterior Anterior Spine: -4.8%; Lateral spine: -5.2%; Total hip: -2.8%; Trochanter: -4.2%; Femoral neck: - 2.4%; Total radius: -3.0% |
Lester et al.[70] | 131 | 500 mg calcium, 400 IU vit D + placebo | 12 months | Lumbar spine: -2.35%; total hip: - 2.27% |
24 months | Lumbar spine: -3.22%; total hip: - 3.90% | |||
Sawka et al.[71] | 70 | 800-1000 IU vit D, 1500 mg elemental calcium (diet+supplements) | 12 months | Lumbar spine: -1.4% |
Femoral Neck: -1.7% |
A = Anastrozole; A+P = Anastrozole+ Placebo